🔎 Trials Near Me

Beranda › Atrofi Geografis › Ohio

Uji klinis Atrofi Geografis di Ohio

7 studi untuk Atrofi Geografis mencari peserta di lokasi di Ohio.

Kota di Ohio

Teks studi resmi (Bahasa Inggris)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Cincinnati Eye Institute, Cincinnati
  • Cleveland Clinic Main Campus, Cleveland
Menerima pesertaFase 2/3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06635148

A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Retina Associates of Cleveland - Beachwood, Beachwood
  • Retina Associates of Cleveland, Cleveland
  • Retina Associates of Cleveland - Middleburg Heights, Middleburg Heights
Menerima pesertaFase 1/2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07029945

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Cincinnati Eye Institute, Cincinnati
  • University Hospitals Cleveland Medical Center, Cleveland
  • The Ohio State University, Columbus
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06659445

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  • Retina Associates of Cleveland, Beachwood
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06662162

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Cleveland Clinic | Cole Eye Institute, Cleveland
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2024 · NCT05438732

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.